{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:03:32Z","timestamp":1784563412355,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","award":["RV144"],"award-info":[{"award-number":["RV144"]}],"id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR","doi-asserted-by":"publisher","award":["109499-61-RKVA"],"award-info":[{"award-number":["109499-61-RKVA"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1125164"],"award-info":[{"award-number":["APP1125164"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005366","name":"American Foundation for Aging Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.xcrm.2021.100386","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T23:22:22Z","timestamp":1630452142000},"page":"100386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination"],"prefix":"10.1016","volume":"2","author":[{"given":"Melissa M.","family":"Lemke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milla R.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Bozich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supachai","family":"Rerks-Ngarm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punnee","family":"Pitisuttithum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorachai","family":"Nitayaphan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Kratochvil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Wines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Mark","family":"Hogarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy W.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly B.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2021.100386_bib1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.xcrm.2021.100386_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2021.100386_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2017.1290018","article-title":"Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design","volume":"13","author":"Jegaskanda","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.xcrm.2021.100386_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12977-018-0457-7","article-title":"HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth","volume":"15","author":"van Schooten","year":"2018","journal-title":"Retrovirology"},{"key":"10.1016\/j.xcrm.2021.100386_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/vim.2010.0108","article-title":"Activation of NK cells by ADCC responses during early HIV infection","volume":"24","author":"Chung","year":"2011","journal-title":"Viral Immunol."},{"key":"10.1016\/j.xcrm.2021.100386_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.chom.2018.07.009","article-title":"A role for Fc function in therapeutic monoclonal antibody-mediated protection against Ebola virus","volume":"24","author":"Gunn","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2021.100386_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2021.100386_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in\u00a0vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100386_bib9","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(08)61593-7","article-title":"Failure of the Merck HIV vaccine: an uncertain step forward","volume":"372","author":"Robb","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2021.100386_bib10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100386_bib11","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100386_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1473-3099(12)70088-9","article-title":"Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B\/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144","volume":"12","author":"Robb","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100386_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12977-018-0438-x","article-title":"Importance of Fc-mediated\u00a0functions of anti-HIV-1 broadly neutralizing antibodies","volume":"15","author":"Parsons","year":"2018","journal-title":"Retrovirology"},{"key":"10.1016\/j.xcrm.2021.100386_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"Hessell","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100386_bib15","doi-asserted-by":"crossref","first-page":"e01120-19","DOI":"10.1128\/JVI.01120-19","article-title":"Boosting with AIDSVAX B\/E enhances env constant region 1 and 2 antibody-dependent cellular cytotoxicity breadth and potency","volume":"94","author":"Easterhoff","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2021.100386_bib16","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2352-3018(19)30406-0","article-title":"Late boosting of the RV144 regimen with AIDSVAX B\/E and ALVAC-HIV in HIV-uninfected Thai volunteers:\u00a0a double-blind, randomised controlled trial","volume":"7","author":"Pitisuttithum","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.xcrm.2021.100386_bib17","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/infdis\/jix099","article-title":"Randomized, double-blind evaluation of late boost strategies for HIV-uninfected vaccine recipients in the RV144 HIV vaccine efficacy trial","volume":"215","author":"Rerks-Ngarm","year":"2017","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100386_bib18","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1016\/S2352-3018(18)30071-7","article-title":"Subtype C ALVAC-HIV and bivalent subtype C gp120\/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1\/2 trial","volume":"5","author":"Bekker","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.xcrm.2021.100386_bib19","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1172\/JCI128699","article-title":"DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial","volume":"129","author":"Rouphael","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2021.100386_bib20","article-title":"Another HIV vaccine strategy fails in large-scale study","author":"Cohen","year":"2020","journal-title":"Science Mag"},{"key":"10.1016\/j.xcrm.2021.100386_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/imm.12861","article-title":"Prospects from systems serology research","volume":"153","author":"Arnold","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.xcrm.2021.100386_bib22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fimmu.2020.00740","article-title":"Fc\u03b3R binding and ADCC activity of human IgG allotypes","volume":"11","author":"de Taeye","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2021.100386_bib23","doi-asserted-by":"crossref","first-page":"228ra38","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2021.100386_bib24","doi-asserted-by":"crossref","first-page":"228ra39","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"Yates","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2021.100386_bib25","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/QAD.0b013e32834b64bd","article-title":"IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation","volume":"25","author":"Forthal","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.xcrm.2021.100386_bib26","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1073\/pnas.96.24.14001","article-title":"Variable efficacy of repeated annual influenza vaccination","volume":"96","author":"Smith","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100386_bib27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/infdis\/jix074","article-title":"Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010\u20132011 to 2014\u20132015","volume":"215","author":"Skowronski","year":"2017","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100386_bib38","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100386_bib28","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4049\/jimmunol.1502551","article-title":"Dimeric Fc\u03b3R ectodomains as probes of the Fc receptor function of anti-influenza virus IgG","volume":"197","author":"Wines","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100386_bib29","doi-asserted-by":"crossref","first-page":"eaaf1483","DOI":"10.1126\/scitranslmed.aaf1483","article-title":"Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection","volume":"9","author":"Parsons","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2021.100386_bib30","doi-asserted-by":"crossref","first-page":"e01823-18","DOI":"10.1128\/JVI.01823-18","article-title":"Two families of env antibodies efficiently engage Fc-\u03b3 receptors and eliminate HIV-1-infected cells","volume":"93","author":"Anand","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2021.100386_bib31","first-page":"jiaa144","article-title":"Multi-functional antibodies are induced by the RTS,S malaria vaccine and associated with protection in a phase I\/IIa trial","author":"Kurtovic","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100386_bib32","doi-asserted-by":"crossref","first-page":"816","DOI":"10.4049\/jimmunol.1602161","article-title":"Dimeric Fc\u03b3 receptor enzyme-linked immunosorbent assay to study HIV-specific antibodies: a new look into breadth of Fc\u03b3 receptor antibodies induced by the RV144 vaccine trial","volume":"199","author":"McLean","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100386_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/infdis\/jix554","article-title":"Antibody-dependent cellular cytotoxicity responses to seasonal influenza vaccination in older adults","volume":"217","author":"Vanderven","year":"2017","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100386_bib34","doi-asserted-by":"crossref","first-page":"e1004185","DOI":"10.1371\/journal.pcbi.1004185","article-title":"Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees","volume":"11","author":"Choi","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.xcrm.2021.100386_bib35","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting\u00a0polyclonal vaccine-induced humoral immunity against HIV using\u00a0systems serology","volume":"163","author":"Chung","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2021.100386_bib36","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm.4105","article-title":"Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251\u00a0acquisition","volume":"22","author":"Vaccari","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100386_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3389\/fimmu.2017.00595","article-title":"A phase 1 human immunodeficiency virus vaccine trial for cross-profiling the kinetics of serum and mucosal antibody responses to CN54gp140 modulated by two homologous prime-boost vaccine regimens","volume":"8","author":"Kratochvil","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2021.100386_bib39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","article-title":"A methodology for performing global uncertainty and sensitivity analysis in systems biology","volume":"254","author":"Marino","year":"2008","journal-title":"J.\u00a0Theor. Biol."},{"key":"10.1016\/j.xcrm.2021.100386_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1051\/mmnp:2008056","article-title":"On the use of the hill functions in mathematical models of gene regulatory networks","volume":"3","author":"Santill\u00e1n","year":"2008","journal-title":"Math. Model. Nat. Phenom."},{"key":"10.1016\/j.xcrm.2021.100386_bib41","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1080\/21645515.2017.1368935","article-title":"Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV","volume":"13","author":"Lloyd","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.xcrm.2021.100386_bib42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1172\/JCI122466","article-title":"Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques","volume":"129","author":"Parsons","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2021.100386_bib43","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1021\/acs.jmedchem.8b01290","article-title":"Synthetic HIV V3 glycopeptide immunogen carrying a N334 N-glycan induces glycan-dependent antibodies with promiscuous site recognition","volume":"61","author":"Cai","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2021.100386_bib44","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3389\/fimmu.2017.01883","article-title":"Immunoglobulin G1 allotype influences antibody subclass distribution in response to HIV gp140 vaccination","volume":"8","author":"Kratochvil","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2021.100386_bib45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4161\/mabs.1.4.9122","article-title":"Human immunoglobulin allotypes: possible implications for immunogenicity","volume":"1","author":"Jefferis","year":"2009","journal-title":"MAbs"},{"key":"10.1016\/j.xcrm.2021.100386_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0090-1229(77)90034-4","article-title":"Population genetics of the human allotypes Gm, Inv, and A2m","volume":"7","author":"Johnson","year":"1977","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.xcrm.2021.100386_bib47","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4049\/jimmunol.1700116","article-title":"Enhanced effector functions due to antibody defucosylation depend on the effector cell Fc\u03b3 receptor profile","volume":"199","author":"Bruggeman","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100386_bib48","doi-asserted-by":"crossref","first-page":"36964","DOI":"10.1038\/srep36964","article-title":"Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans","volume":"6","author":"Dekkers","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2021.100386_bib49","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1073\/pnas.1702173114","article-title":"Modulating IgG effector function by Fc glycan engineering","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100386_bib50","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1080\/19420862.2016.1218586","article-title":"The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc \u03b3 receptor","volume":"8","author":"Subedi","year":"2016","journal-title":"MAbs"},{"key":"10.1016\/j.xcrm.2021.100386_bib51","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1097\/QAD.0000000000000444","article-title":"Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function","volume":"28","author":"Chung","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.xcrm.2021.100386_bib52","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2012-05-431361","article-title":"Association of Fc\u03b3 receptor IIIa genotype with the rate of HIV infection after gp120 vaccination","volume":"120","author":"Forthal","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100386_bib53","doi-asserted-by":"crossref","first-page":"e1005456","DOI":"10.1371\/journal.ppat.1005456","article-title":"Antigen-specific antibody glycosylation is regulated via vaccination","volume":"12","author":"Mahan","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2021.100386_bib54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12977-017-0380-3","article-title":"Systems serology: profiling vaccine induced humoral immunity against HIV","volume":"14","author":"Chung","year":"2017","journal-title":"Retrovirology"},{"key":"10.1016\/j.xcrm.2021.100386_bib55","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/cid\/cix057","article-title":"Virus-driven inflammation is associated with the development of bNAbs in spontaneous controllers of HIV","volume":"64","author":"Dugast","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100386_bib56","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41467-021-22236-7","article-title":"Systems serology detects functionally distinct coronavirus antibody features in children and elderly","volume":"12","author":"Selva","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2021.100386_bib57","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1038\/s41467-020-19545-8","article-title":"Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19","volume":"11","author":"Tosif","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2021.100386_bib58","doi-asserted-by":"crossref","first-page":"e00700-17","DOI":"10.1128\/JVI.00700-17","article-title":"HIV-1 env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV","volume":"91","author":"Madhavi","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2021.100386_bib59","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/CVI.00478-08","article-title":"Serologic assay to quantify human immunoglobulin G antibodies to the Staphylococcus aureus iron surface determinant B antigen","volume":"16","author":"Raedler","year":"2009","journal-title":"Clin. Vaccine Immunol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121002445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121002445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:47:56Z","timestamp":1762987676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379121002445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2666379121002445"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100386","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"100386"}}